Yu-Wei Lin
- Molecular Medicine top 2%
- Molecular Biology
- Pharmacology top 10%
- Ecology
- Epidemiology
- Topics
- Antibiotic Resistance in Bacteria (10 papers)Pneumonia and Respiratory Infections (5 papers)Antibiotics Pharmacokinetics and Efficacy (5 papers)
- Partner nations
- AustraliaUnited StatesTaiwan
In The Last Decade
Yu-Wei Lin
16 papers receiving 505 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 174
- Molecular Biology 146
- Pharmacology 103
- Ecology 100
- Epidemiology 97
Countries citing papers authored by Yu-Wei Lin
This map shows the geographic impact of Yu-Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Wei Lin more than expected).
Fields of papers citing papers by Yu-Wei Lin
This network shows the impact of papers produced by Yu-Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Wei Lin. The network helps show where Yu-Wei Lin may publish in the future.
Co-authorship network of co-authors of Yu-Wei Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Wei Lin. A scholar is included among the top collaborators of Yu-Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Wei Lin. Yu-Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 100 | |
| 4 | 6 | |
| 5 | 18 | |
| 6 | 18 | |
| 7 | 95 | |
| 8 | 36 | |
| 9 | 14 | |
| 10 | 17 | |
| 11 | 50 | |
| 12 | 15 | |
| 13 | 15 | |
| 14 | 36 | |
| 15 | 21 | |
| 16 | 49 | |
| 17 | 17 |
About Yu-Wei Lin
Yu-Wei Lin is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 17 papers that have together received 508 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Molecular Medicine (174 citations), Applied Microbiology and Biotechnology (32 citations) and Microbiology (46 citations). Yu-Wei Lin has collaborated with scholars based in Australia, United States and Taiwan. Frequent co-authors include Jian Li, Qi Zhou, Hak‐Kim Chan, Jui‐I Chao, Kuang‐Kai Liu, Chinpiao Chen, Ke Chen, Alan Forrest, Mei‐Ling Han and Jinxin Zhao. Their work appears in journals such as Advanced Drug Delivery Reviews, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.